Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Nanox to Present at the Cantor Fitzgerald Global Healthcare Conference 2023 in September
-
Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference
-
Anteris Announces Participation at the Cantor Healthcare Conference on Sept 26th 2023
-
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Sanara MedTech to Participate in Two Upcoming Conferences
-
Cantor on Lyra Therapeutics (LYRA):'Better-Than-Expected BEACON Results Expand Opportunity for LYRA's CRS Platform'
-
Acelyrin (SLRN) crashes 60% as lead product misses in study; Seen as a 'big positive' for MoonLake (MLTX)
-
CymaBay Therapeutics (CBAY) Prices Upsized $225M Share and Warrant Offering at $17.13/sh
-
CymaBay Announces Pricing of Upsized $225 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Mineralys Therapeutics to Participate in the Cantor Fitzgerald Global Healthcare Conference on Thursday, September 28, 2023
-
Orchid Island Capital Announces September 2023 Monthly Dividend and August 31, 2023 RMBS Portfolio Characteristics
-
Artificial Intelligence-Driven Predictive Medical Diagnostics Company Spectral MD Announces Closing of Business Combination
-
Avertix to Present at Two Upcoming Investor Conferences in September 2023
-
CymaBay Therapeutics (CBAY) Announces Proposed $150M Share and Warrant Offering
-
CymaBay Announces Proposed $150 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Sprott Physical Uranium Trust Announces Updated “At-The-Market” Equity Program
-
Cantor Fitzgerald Starts Atossa Genetics (ATOS) at Overweight, 'Changing the Treatment Paradigm in Breast Cancer'
-
4DMT to Participate in Upcoming Investor Conferences
-
Cytokinetics to Participate in Upcoming Investor Conferences
-
Mustang Bio to Participate in Upcoming September 2023 Investor Conferences
-
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Form 8-K Cantor Fitzgerald Income For: Sep 06
-
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Daré Bioscience to Participate in Upcoming Investor Conferences
-
Rani Therapeutics to Participate in September Investor Conferences
-
Aston Bay Holdings Ltd. Announces C$5.0M Brokered Financing
-
Werewolf Therapeutics to Participate in Upcoming Investor Conferences
-
Alkermes to Participate in Two Upcoming Investor Conferences
-
MIMEDX to Present at Upcoming Investor Conferences
-
OmniAb to Participate in Two Investor Conferences in September
-
Cantor Fitzgerald Bolsters Healthcare and Biotechnology Equity Research Team with Addition of Josh Schimmer, M.D., and Eric Schmidt, Ph.D.
-
Arrowhead Pharmaceuticals to Participate in Upcoming September 2023 Conferences
-
Intuitive Machines (LUNR) Announces $20M Equity Investment
-
Intuitive Machines Announces $20 Million Equity Investment
-
DURECT Corporation Announces Presentations in Upcoming Investor Conferences
-
Galecto to Present at Investor Conferences in September
-
UroGen Pharma to Present at Upcoming Investor Conferences
-
Axogen to Participate at Upcoming Investor Conferences
-
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
-
Clene to Present at Upcoming September Conferences
-
APNIMED to Participate in Upcoming Investor Conferences in September
-
Compass Therapeutics to Participate in Upcoming Investor Events
-
Cognition Therapeutics Announces Participation in Upcoming September Conferences
-
LifeMD to Participate in Two Investor Conferences in September
-
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
-
Form NPORT-P CANTOR FITZGERALD SUSTAI For: Jun 30
-
Absci to Participate in Upcoming Investor Conferences
-
SCYNEXIS to Participate in September Investor Conferences
-
Cantor Starts NextGen Healthcare Inc (NXGN) at Overweight, 'attractive investment profile that is not fully reflected'
-
Cantor Fitzgerald Upgrades Ardelyx, Inc (ARDX) to Overweight

